ImageneBio, Inc. (IMA) vs Lite Strategy, Inc. (LITS)

ImageneBio, Inc. and Lite Strategy, Inc. are both Biotechnology companies. ImageneBio, Inc. and Lite Strategy, Inc. are of similar size ($52.9M and $51.0M). Lite Strategy, Inc. grew revenue faster over the last twelve months: 152.9% against −68.0%. Across the 14 metrics below, ImageneBio, Inc. leads on 7 and Lite Strategy, Inc. on 7.

Valuation

Metric IMA LITS Biotechnology median
P/E n/m n/m 7.88
P/S 12.42 0.49 11.47
P/B 0.54 0.90 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 4.31 0.42 10.73
Earnings yield (110.51%) (139.13%) (28.84%)
Free cash flow yield (67.66%) (20.24%) (23.03%)

Profitability

Metric IMA LITS Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (41.34%) (159.26%) (57.72%)
Return on assets (38.34%) (154.82%) (49.22%)
Return on invested capital (622.37%) (73.66%) 0.00%

Growth

Metric IMA LITS Biotechnology median
Revenue growth (TTM) (67.95%) 152.90% 5.64%
EPS growth (last fiscal year) 21.27% (189.51%) —
Revenue growth, 5-year CAGR (38.64%) 67.75% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMA LITS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 21.47 11.53 4.73
Net debt to EBITDA 2.85 1.05 0.96

Dividend

Metric IMA LITS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric IMA LITS Biotechnology median
Market cap 52.90m 51.04m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack